NCT02321150

Brief Summary

The aim of this study is to introduce a new surgical technique for the removal of pterygiums that entails the use of bipolar electrocautery to secure the graft, rather than sutures. With this, the objective is to evaluate the benefits of a new technique for pterygium surgery with respect to postoperative patient comfort, surgery time, cost and recurrence rate.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

December 3, 2014

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 22, 2014

Completed
Last Updated

December 30, 2014

Status Verified

December 1, 2014

Enrollment Period

1 year

First QC Date

December 3, 2014

Last Update Submit

December 26, 2014

Conditions

Keywords

PterygiumPterygiumsPterygiaGraftAutograftExcisionSurgeryEyeelectrocauterypolyglactin

Outcome Measures

Primary Outcomes (6)

  • Patient Discomfort

    Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4: 0 = no symptom at all; 1. = presence of the symptom but easily tolerated; 2. = presence of the symptom causing some discomfort; 3. = presence of the symptom causing discomfort that interferes with usual activity or sleep; 4. = presence of the symptom that completely interferes with usual activity or sleep.

    Day 1

  • Patient Discomfort

    Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4: 0 = no symptom at all; 1. = presence of the symptom but easily tolerated; 2. = presence of the symptom causing some discomfort; 3. = presence of the symptom causing discomfort that interferes with usual activity or sleep; 4. = presence of the symptom that completely interferes with usual activity or sleep.

    Week 1

  • Patient Discomfort

    Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4: 0 = no symptom at all; 1. = presence of the symptom but easily tolerated; 2. = presence of the symptom causing some discomfort; 3. = presence of the symptom causing discomfort that interferes with usual activity or sleep; 4. = presence of the symptom that completely interferes with usual activity or sleep.

    Week 2

  • Patient Discomfort

    Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4: 0 = no symptom at all; 1. = presence of the symptom but easily tolerated; 2. = presence of the symptom causing some discomfort; 3. = presence of the symptom causing discomfort that interferes with usual activity or sleep; 4. = presence of the symptom that completely interferes with usual activity or sleep.

    Week 3

  • Patient Discomfort

    Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4: 0 = no symptom at all; 1. = presence of the symptom but easily tolerated; 2. = presence of the symptom causing some discomfort; 3. = presence of the symptom causing discomfort that interferes with usual activity or sleep; 4. = presence of the symptom that completely interferes with usual activity or sleep.

    Week 7

  • Patient Discomfort

    Grading of patients' symptoms (pain, foreign body sensation, irritation, and epiphora) will be done using a 5-point scale. The scale ranges from 0 to 4: 0 = no symptom at all; 1. = presence of the symptom but easily tolerated; 2. = presence of the symptom causing some discomfort; 3. = presence of the symptom causing discomfort that interferes with usual activity or sleep; 4. = presence of the symptom that completely interferes with usual activity or sleep.

    3 months

Secondary Outcomes (1)

  • Operating time

    day 1

Other Outcomes (2)

  • Operating Cost

    day 1

  • Recurrence

    1 year

Study Arms (2)

Sutures

ACTIVE COMPARATOR

After pterygium removal the conjunctival graft to cover bare sclera will be secured with interrupted 8.0 polyglactin sutures.

Procedure: Sutures

Cautery

EXPERIMENTAL

After pterygium removal the conjunctival graft to cover bare sclera will be secured with bipolar electrocautery, power set at 25 until whitening of tissue observed.

Procedure: Cautery

Interventions

CauteryPROCEDURE

* Pterygium dissected off, corneal bed burred smooth and autograft harvested as per usual technique. * Conjunctiva undermined at the recipient site. * Relaxing incisions placed at the corners of the recipient site. * Graft is slid into place * Graft / host interface is gently dried with a Qtip * Bipolar cautery is applied after grasping the graft and host conjunctiva gently between cautery forceps. * Power setting: 25. * Duration of cautery: 4 -5 seconds; the tissue should whiten and contract as desiccation and coagulation take place. Some charring may occur. * Counter traction is applied to the conjunctiva as the cautery forceps are gently teased off * Cautery is applied at the 4 apices of the graft then in between these points.

Also known as: Mentor O&O Wetfield Coagulator
Cautery
SuturesPROCEDURE

* Pterygium dissected off, corneal bed burred smooth and autograft harvested as per usual technique. * Conjunctiva undermined at the recipient site. * Graft is slid into place The graft is secured to host conjunctiva using 7 interrupted sutures

Also known as: Polyglactin, Vicryl
Sutures

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with one or more pterygiums over age 18

You may not qualify if:

  • Patients with glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth Hospital

Bridgetown, Barbados

Location

MeSH Terms

Conditions

Pterygium

Interventions

CauterySuturesPolyglactin 910

Condition Hierarchy (Ancestors)

Conjunctival DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, OperativeSurgical Fixation DevicesSurgical EquipmentEquipment and SuppliesPolyestersPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Kim N Jebodhsingh, MBBS, DABO

    The Queen Elizabeth Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Ophthalmologist

Study Record Dates

First Submitted

December 3, 2014

First Posted

December 22, 2014

Study Start

December 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

December 30, 2014

Record last verified: 2014-12

Locations